TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,724 | -$35,959 | -$20 | -$16,199 |
| Dep. & Amort. | $188 | $126 | $100 | $154 |
| Deferred Tax | $14,582 | -$1,073 | $0 | -$43 |
| Stock-Based Comp. | $5,680 | $3,385 | $3,708 | $351 |
| Change in WC | $1,082 | -$2,813 | $1,413 | -$231 |
| Other Non-Cash | -$6,697 | $3,968 | -$17,990 | $41 |
| Operating Cash Flow | -$34,889 | -$32,366 | -$12,769 | -$15,928 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$77 | -$515 | -$67 | -$29 |
| Net Acquisitions | $0 | -$12,848 | $0 | $0 |
| Inv. Purchases | -$24,411 | -$66,295 | $0 | $0 |
| Inv. Sales/Matur. | $59,936 | $25,663 | $0 | $5,526 |
| Other Inv. Act. | $36 | $20 | $0 | $6 |
| Investing Cash Flow | $35,448 | -$53,975 | -$67 | $5,497 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$825 | $44,147 | $14,235 | $4,935 |
| Stock Issued | $2,615 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $31 | $201 | $110 | $2 |
| Financing Cash Flow | $1,790 | $44,348 | $63,460 | $4,936 |
| Forex Effect | -$119 | -$69 | $0 | $0 |
| Net Chg. in Cash | $2,229 | -$42,062 | $50,624 | -$5,494 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,073 | $55,136 | $4,512 | $10,006 |
| End Cash | $15,302 | $13,073 | $55,136 | $4,512 |
| Free Cash Flow | -$34,967 | -$32,881 | -$12,836 | -$15,956 |